Contact this trialFirst, we need to learn more about you.
Aromatase Inhibitor
Letrozole for Breast Cancer
Recruiting3 awardsPhase 2
Jacksonville, Florida
This trial tests letrozole, a drug that lowers estrogen levels, in patients with a specific type of breast cancer that can be surgically removed. By reducing estrogen, letrozole can help slow or stop the growth of these cancer cells. Letrozole is a highly specific and potent aromatase inhibitor that has been shown to significantly reduce estrogen levels and is used in various breast cancer treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service